Zemplar and acute myocardial infarction Patient Reports February 10, 2012

Zemplar Side Effects Report #5152733-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 06, 2006. Female patient, weighting 141.1 lb, was diagnosed with renal failure chronic, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, bundle branch block right, cardiac arrest , left ventricular failure, mitral valve incompetence, pulmonary oedema, ventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with TELMISARTAN, FUROSEMIDE, SORTIS. Patient was hospitalized. Patient died on 10/17/2006.

Zemplar Side Effects Report #5416075-7
Zemplar side effect was reported by a Physician from PUERTO RICO on Aug 10, 2007. Male patient, 72 years of age, was diagnosed with renal failure, cardiac failure congestive and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, fall , hypercalcaemia, subdural haematoma. Zemplar dosage: unknown. During the same period patient was treated with CADUET, CARVEDILOL, IMDUR, LOSARTAN POTASSIUM. Patient was hospitalized. Patient died on 07/20/2007.

Zemplar Side Effects Report #5227864-6
Zemplar side effect was reported by a Physician from AUSTRIA on Jan 25, 2007. Female patient, 72 years of age, weighting 260.1 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, cardiac failure, cardiac failure congestive, gastritis, diabetes mellitus non-insulin-dependent and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with DIGIMERK, CLOPIDOGREL BISULPHATE, PANTOPRAZOLE, INSULIN ISOPHANE SEMISYNTHETIC, INSULIN LISPRO. Patient died on 09/21/2006.

Zemplar Side Effects Report #5385887-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on July 03, 2007. Male patient, 65 years of age, weighting 140.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine deficiency, muscle spasms, multi-vitamin deficiency, peripheral vascular disorder, gastritis, hypertension, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, LEVOCARNITINE, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ESOMEPRAZOLE MAGNESIUM, SEVELAMER, CALCIUM CARBONATE. Patient was hospitalized. Patient died on 07/02/2007.


Zemplar Side Effects Report #4958455-X
Zemplar side effect was reported by a Physician from AUSTRALIA on Mar 20, 2006. Male patient, 62 years of age, weighting 255.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with DREISACARB, ALFACALCIDOL, CANDESARTAN CILEXETIL, AMLODIPINE, THEOPHYLLINE, PULMILIDE DA, PANTOPRAZOLE. Patient died on 02/25/2006.

Zemplar Side Effects Report #6075386-5
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 05, 2009. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, MIMPARA, FORSENOL, EVATON, INTELLECTA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6091469-8
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 19, 2009. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, renal failure chronic, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ARANESP, MIMPARA, FORSENOL, EVATON, INTELLECTA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5254389-4
Zemplar side effect was reported by a Physician from GERMANY on Feb 21, 2007. Female patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5267591-2
Zemplar side effect was reported by a Physician from GERMANY on Mar 08, 2007. Female patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 03/01/2007.


Zemplar Side Effects Report #5285137-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Mar 26, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5285344-6
Zemplar side effect was reported by a Physician from GERMANY on Mar 26, 2007. Female patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 03/01/2007.

Zemplar Side Effects Report #5303778-8
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 11, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, renal failure chronic, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5321880-1
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Apr 30, 2007. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, coronary artery disease , dyspnoea, full blood count decreased, left ventricular failure, occult blood positive, supraventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDTE, ASASANTIN, OMEPRAZOLE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5195459-9
Zemplar side effect was reported by a Physician from GERMANY on Aug 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, angina pectoris, blood alkaline phosphatase increased, blood parathyroid hormone increased, blood phosphorus increased, cardiac failure congestive, pulmonary congestion, shock. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ALUMINIUM HYDROXIDE GEL, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 05/12/2006.


Zemplar Side Effects Report #5405219-9
Zemplar side effect was reported by a Physician from GERMANY on July 24, 2007. Female patient, weighting 138.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with DIGIMERCK, METOPROLOL SUCCINATE, THEOPHYLLINE, FEXOFENADINE, PANTOPRAZOLE, OMEPRAZOL DURA, FERRLECIT, EPOETIN ALFA. Patient was hospitalized. Patient died on 03/01/2007.

Zemplar Side Effects Report #5410926-8
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, weighting 132.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, hypercalcaemia, renal failure acute. Zemplar dosage: unknown. During the same period patient was treated with CINACALCET HYDROCHLORIDE. Patient died on 07/26/2007.

Zemplar Side Effects Report #5499832-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 18, 2007. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5518785-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Nov 05, 2007. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia, hyperuricaemia, hypertension, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema, coronary artery disease , sinus tachycardia. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, FILICIN, ALLOPURINOL, QUINAPRIL, AMLODIPINE, CALCIUM CARBONATE, NEUROBION. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5588804-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 03, 2008. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia, hyperuricaemia, hypertension, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, FILICIN, ALLOPURINOL, QUINAPRIL, AMLODIPINE, CALCIUM CARBONATE, NEUROBION. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5588891-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 03, 2008. Female patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency, carnitine, thrombosis prophylaxis, hyperphosphataemia, vitamin supplementation, type 2 diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, SACCHARATED IRON OXIDE, SUPERAMINE, TICLOPIDINE HYDROCHLORIDE, CALCIUM CARBONATE, VITAMEDIN INTRAVENOUS, BIOTINE, GLIMEPIRIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5622428-4
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 06, 2008. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia, hyperuricaemia, hypertension, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, FILICIN, ALLOPURINOL, QUINAPRIL, AMLODIPINE, CALCIUM CARBONATE, NEUROBION. Patient was hospitalized. Patient died on 02/06/2008.

Zemplar Side Effects Report #5699549-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 31, 2008. Male patient, weighting 130.1 lb, was diagnosed with hyperparathyroidism secondary, anaemia, iron deficiency anaemia, hyperuricaemia, hypertension, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, acute pulmonary oedema, cardio-respiratory arrest. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, FILICIN, ALLOPURINOL, QUINAPRIL, AMLODIPINE, CALCIUM CARBONATE, NEUROBION. Patient was hospitalized. Patient died on 02/06/2008.

Zemplar Side Effects Report #5800107-8
Zemplar side effect was reported by a Physician from GERMANY on June 26, 2008. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, acute myocardial infarction, angina pectoris, cardiac disorder, coronary artery disease , coronary artery occlusion. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.

Zemplar Side Effects Report #5879516-7
Zemplar side effect was reported by a Consumer or non-health professional from MEXICO on Sept 09, 2008. Male patient, weighting 194.0 lb, was diagnosed with hyperparathyroidism secondary, dyslipidaemia, cardiovascular event prophylaxis, cardiovascular disorder, oedema, hypertension, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ATORVASTATIN, ACETYLSALICYLIC ACID SRT, EPLERENONE, FUROSEMIDE, ENALAPRIL MALEATE, SEVELAMER. Patient died on 09/01/2008.


Zemplar Side Effects Report #4974453-4
Zemplar side effect was reported by a Physician from SPAIN on Mar 28, 2006. Male patient, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac failure, congestive cardiomyopathy, dyspnoea, electrocardiogram st segment elevation, ischaemic cardiomyopathy, mitral valve incompetence, oedema peripheral, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, FOLIC ACID, TAMSULOSIN, VITAMINES, OMEPRAZOLE, EPOETIN ALFA, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5136381-3
Zemplar side effect was reported by a Physician from AUSTRIA on Sept 24, 2006. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac arrest , cardiogenic shock, multi-organ failure. Zemplar dosage: unknown. During the same period patient was treated with FOSRENOL, DARBEPOETIN ALFA, FOLIC ACID, NULYTELY, PRAVASTATIN, ASPIRIN, TRIAZOLAM, GLYCERYL TRINITRATE. Patient was hospitalized. Patient died on 08/29/2006.

Zemplar Side Effects Report #6105818-5
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2009. Female patient, weighting 121.3 lb, was diagnosed with hyperparathyroidism, renal failure chronic, hypertension, renal disorder, blood phosphorus increased, gastrooesophageal reflux disease, blood cholesterol increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, failure to thrive. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, LABETALOL, LASIX, NIFEDIPINE, PHOSLO, PROTONIX, LIPITOR. Patient was hospitalized. Patient died on 02/05/2009.

Zemplar Side Effects Report #5321885-0
Zemplar side effect was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, weighting 88.18 lb, was diagnosed with glomerulonephritis, hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac failure congestive, cardio-respiratory arrest, gastroenteritis , hepatitis cholestatic, hypertension, renal failure chronic. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ISOSORBIDE MONONITRATE, AMLODIPINE BESYLATE, LABETALOL, QUININE SULPHATE. Patient was hospitalized. Patient died on 10/25/2005.